Esperante Ventures Overview
Esperante Ventures, established in 2004, is a private limited company based in Hoofddorp, Netherlands. The firm focuses on seed investments in the biotechnology and healthcare sectors, leveraging extensive industry expertise and a robust network to support portfolio companies, particularly in business development.
Is Esperante Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Esperante Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Esperante Ventures
Investment focus
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A, Series B or later
First ticket size
€100,000 - €1,500,000
Contact information
Investment Analyst
Andrew Edmonds
Managing Director
Dean Slagel
How to approach funds like Esperante Ventures
When approaching Esperante Ventures, emphasize your company's potential for rapid progression to clinical development and a clear path to financial independence or exit within five years. Highlight your team's relevant experience and your business model's scalability, as Esperante seeks to invest €300,000 to €700,000 for equity stakes ranging from 3% to 33%. Demonstrating a well-defined strategy for achieving significant milestones will align with their investment criteria.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
